Peptide holds promise of new therapeutic approach
A nasal spray that delivers a peptide to treat depression holds promise as a potential alternative therapeutic approach, research from the Centre for Addiction and Mental Health (CAMH) shows.
The study, led by CAMH’s Dr. Fang Liu, is published online in Neuropsychopharmacology.
In a previous study published in Nature Medicine in 2010, Dr. Liu developed a protein peptide that provided a highly targeted approach to treating depression that she hopes will have minimal side effects. The peptide was just as effective in relieving symptoms when compared to a conventional antidepressant in animal testing. However, the peptide had to be injected into the brain. Taken orally, it would not cross the blood-brain barrier in sufficient concentrations.
“Clinically, we needed to find a non-invasive, convenient method to deliver this peptide treatment,” says Dr. Liu, Senior Scientist in the Campbell Family Mental Health Research Institute at CAMH. With the support of a Proof of Principle grant from the Canadian Institutes of Health Research (CIHR), Dr. Liu’s team was able to further explore novel delivery methods.
The nasal delivery system, developed by U.S. company Impel NeuroPharma, was shown to deliver the peptide to the right part of the brain. It also relieved depression-like symptoms in animals.
“This study marks the first time a peptide treatment has been delivered through nasal passageways to treat depression,” says Dr. Liu, Professor in the University of Toronto’s Department of Psychiatry.
The peptide treatment interferes with the binding of two dopamine receptors – the D1 and D2 receptor complex. Dr. Liu’s team had found that this binding was higher in the brains of people with major depression. Disrupting the binding led to the anti-depressant effects.
The peptide is an entirely new approach to treating depression, which has previously relied on medications that primarily block serotonin or norepinephrine transporters.
Depression, the most common form of mental illness, is one of the leading causes of disability globally. More than 50 per cent of people living with depression do not respond to first-line medication treatment.
“This research brings us one step closer to clinical trials,” says Dr. Liu. In ongoing lab research, her team is experimenting to determine if they can make the peptide break down more slowly, and travel more quickly in the brain, to improve its anti-depressant effects.
The Latest on: Depression
[google_news title=”” keyword=”Depression” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Depression
- Depression Drains the Polish Economyon May 11, 2024 at 2:23 am
Based on the report's authors' calculations, depression in Poland results in losses of at least PLN 2.8 billion, just in sick leave costs. Experts commenting on the results also indicate that the main ...
- Portland Sea Dogs slugger shares his struggles with anxiety, depressionon May 10, 2024 at 5:00 pm
It was then that Jordan – a slugging corner infielder for the Portland Sea Dogs – finally confronted the anxiety and depression that was consuming his life. The coronavirus pandemic had shuttered the ...
- How Gut Bacteria and Depression Are Connectedon May 10, 2024 at 12:22 pm
Your gut houses trillions of bacteria and millions of nerve cells that manage your digestive processes. These bacteria and nerve cells might also affect how you feel. Which means when you feel happy, ...
- Researchers show impact of insomnia and depression on asthma controlon May 10, 2024 at 10:11 am
Researchers at National Jewish Health have shown that underlying mood and sleep disorders negatively impact asthma control. Data reveal a considerable interaction between insomnia, depression and ...
- Depression and suicide risk can intensify in spring and summeron May 10, 2024 at 10:00 am
May is Mental Health Awareness Month. Intense symptoms for individuals with depression are commonly associated with the winter and holiday season, depression and suicidal thoughts are actually more ...
- Expert on depression, anxiety explains how struggling Christians can begin to find hopeon May 10, 2024 at 9:39 am
For many Christians who struggle with clinical depression and anxiety, the pressure to always appear joyful can exacerbate anxious feelings and despair, according to Jason Jimenez, founder of Stand ...
- Customized Video Games Promising for ADHD, Depression, in Kidson May 10, 2024 at 7:16 am
Gamified digital mental health interventions may be an effective "bridge" therapy to reduce symptoms of ADHD and depression in children and adolescents.
- Michael Phelps reflects on his depression and the ‘great change’ that came from iton May 10, 2024 at 5:42 am
Michael Phelps is opening up about how he came to grips with the knowledge he suffered from depression. In a preview clip for the upcoming May 12 episode of NBC’s “Meet the Press,” Kristen Welker ...
- A New Study Is Finally Attempting to Pin Down The Root Causes of Depressionon May 10, 2024 at 5:00 am
Researchers are gaining a better understanding that depression is a large family of illnesses with different causes and mechanisms.
- 'Rich Dad Poor Dad' Author Robert Kiyosaki Shares 6 Tips To Survive Economic Depression And 'Get Rich'on May 10, 2024 at 4:26 am
Survive and thrive through an economic depression with tips from "Rich Dad Poor Dad" Robert Kiyosaki . Build emergency funds, pay off debt, organize investments, live within means, upskill, and ...
via Bing News